James Dignam

A Multiresolution Hazard Model for Multicenter Survival Studies

Vanja Dukić, Xiao-Li Meng, Peter Bouman, 2007, Journal of the American Statistical Association.

RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).

Robert Jeraj, Maria Werner-Wasik, Deborah T Blumenthal, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance.

Walter J Curran, Richard Simon, J Jack Lee, 2012, International journal of radiation oncology, biology, physics.

Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time

Milica Medved, Walter M Stadler, James Dignam, 2004, Journal of magnetic resonance imaging : JMRI.

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

James Dignam, Norman Wolmark, Mirsada Begovic, 1999, The Lancet.

Benefits and costs of interventions to improve breast cancer outcomes in African American women.

Peter Muennig, Jennifer Cullen, James Dignam, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.